Oil & Gas Exploration & Production
Build Your Comparison
Side-by-side financial analysisStock Comparison
KGEI vs TPVG vs JPM vs BAC vs HRZN
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Banks - Diversified
Banks - Diversified
Asset Management
KGEI vs TPVG vs JPM vs BAC vs HRZN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Oil & Gas Exploration & Production | Asset Management | Banks - Diversified | Banks - Diversified | Asset Management |
| Market Cap | $190M | $226M | $896.00B | $422.78B | $192M |
| Revenue (TTM) | $64M | $61M | $280.33B | $191.57B | $75M |
| Net Income (TTM) | $14M | $-12M | $57.05B | $30.51B | $28M |
| Gross Margin | 58.3% | 72.9% | 60.0% | 56.1% | 35.7% |
| Operating Margin | 45.9% | -35.9% | 25.9% | 19.7% | 26.0% |
| Forward P/E | 7.3x | 6.0x | 14.4x | 12.6x | 6.5x |
| Total Debt | $50M | $469M | $942.38B | $365.90B | $473M |
| Cash & Equiv. | $3M | $20M | $343.34B | $231.84B | $106M |
KGEI vs TPVG vs JPM vs BAC vs HRZN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 23 | Jun 26 | Return |
|---|---|---|---|
| Kolibri Global Ener… (KGEI) | 100 | 125.2 | +25.2% |
| TriplePoint Venture… (TPVG) | 100 | 58.9 | -41.1% |
| JPMorgan Chase & Co. (JPM) | 100 | 230.6 | +130.6% |
| Bank of America Cor… (BAC) | 100 | 212.7 | +112.7% |
| Horizon Technology … (HRZN) | 100 | 39.4 | -60.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: KGEI vs TPVG vs JPM vs BAC vs HRZN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
KGEI ranks third and is worth considering specifically for efficiency.
- 4.9% ROA vs TPVG's -1.5%, ROIC 7.5% vs 7.2%
TPVG has the current edge in this matchup, primarily because of its strength in growth exposure and bank quality.
- Rev growth 36.6%, EPS growth 48.8%
- NIM 7.4% vs BAC's 1.8%
- 36.6% NII/revenue growth vs KGEI's -22.4%
- Beta 0.65 vs JPM's 0.94, lower leverage
JPM is the clearest fit if your priority is long-term compounding.
- 465.8% 10Y total return vs BAC's 368.2%
- 1.9% yield, 15-year raise streak, vs HRZN's 28.8%, (1 stock pays no dividend)
BAC is the clearest fit if your priority is momentum.
- +28.1% vs HRZN's -26.7%
HRZN is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 1 yrs, beta 0.85, yield 28.8%
- Lower volatility, beta 0.85, current ratio 1.24x
- PEG 0.27 vs TPVG's 5.88
- Beta 0.85, yield 28.8%, current ratio 1.24x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 36.6% NII/revenue growth vs KGEI's -22.4% | |
| Value | Lower P/E (6.5x vs 12.6x), PEG 0.27 vs 0.82 | |
| Quality / Margins | 37.4% margin vs TPVG's -19.5% | |
| Stability / Safety | Beta 0.65 vs JPM's 0.94, lower leverage | |
| Dividends | 1.9% yield, 15-year raise streak, vs HRZN's 28.8%, (1 stock pays no dividend) | |
| Momentum (1Y) | +28.1% vs HRZN's -26.7% | |
| Efficiency (ROA) | 4.9% ROA vs TPVG's -1.5%, ROIC 7.5% vs 7.2% |
KGEI vs TPVG vs JPM vs BAC vs HRZN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
KGEI vs TPVG vs JPM vs BAC vs HRZN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HRZN leads in 2 of 6 categories
KGEI leads 1 • JPM leads 1 • TPVG leads 0 • BAC leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HRZN leads this category, winning 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 4596.3x TPVG's $61M. HRZN is the more profitable business, keeping 37.4% of every revenue dollar as net income compared to TPVG's -19.5%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $64M | $61M | $280.3B | $191.6B | $75M |
| EBITDAEarnings before interest/tax | $47M | -$22M | $81.4B | $40.0B | $19M |
| Net IncomeAfter-tax profit | $14M | -$12M | $57.0B | $30.5B | $28M |
| Free Cash FlowCash after capex | -$14M | -$59M | $100.9B | $12.6B | $67M |
| Gross MarginGross profit ÷ Revenue | +58.3% | +72.9% | +60.0% | +56.1% | +35.7% |
| Operating MarginEBIT ÷ Revenue | +45.9% | -35.9% | +25.9% | +19.7% | +26.0% |
| Net MarginNet income ÷ Revenue | +21.7% | -19.5% | +20.4% | +15.9% | +37.4% |
| FCF MarginFCF ÷ Revenue | -22.8% | -97.1% | +36.0% | +6.6% | +89.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -6.9% | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -31.3% | -2.3% | +16.0% | +18.3% | -29.6% |
Valuation Metrics
HRZN leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 4.2x trailing earnings, HRZN trades at a 74% valuation discount to JPM's 16.0x P/E. Adjusting for growth (PEG ratio), HRZN offers better value at 0.17x vs TPVG's 4.50x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $190M | $226M | $896.0B | $422.8B | $192M |
| Enterprise ValueMkt cap + debt − cash | $238M | $675M | $1.50T | $556.8B | $560M |
| Trailing P/EPrice ÷ TTM EPS | 12.47x | 4.57x | 16.00x | 14.66x | 4.15x |
| Forward P/EPrice ÷ next-FY EPS est. | 7.34x | 5.96x | 14.40x | 12.56x | 6.50x |
| PEG RatioP/E ÷ EPS growth rate | — | 4.50x | 0.90x | 0.95x | 0.17x |
| EV / EBITDAEnterprise value multiple | 5.82x | 8.91x | 18.36x | 13.92x | — |
| Price / SalesMarket cap ÷ Revenue | 3.29x | 2.33x | 3.20x | 2.21x | 4.81x |
| Price / BookPrice ÷ Book value/share | 0.96x | 0.63x | 2.47x | 1.39x | 0.58x |
| Price / FCFMarket cap ÷ FCF | — | — | 8.88x | 33.52x | 3.40x |
Profitability & Efficiency
KGEI leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-3 for TPVG. KGEI carries lower financial leverage with a 0.25x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), BAC scores 7/9 vs TPVG's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +6.8% | -3.4% | +15.9% | +10.1% | +9.0% |
| ROA (TTM)Return on assets | +4.9% | -1.5% | +1.3% | +0.9% | +3.6% |
| ROICReturn on invested capital | +7.5% | +7.2% | +4.5% | +3.5% | -0.2% |
| ROCEReturn on capital employed | +9.3% | +9.4% | +8.9% | +4.5% | -0.2% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 | 5 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.25x | 1.33x | 2.60x | 1.21x | 1.49x |
| Net DebtTotal debt minus cash | $48M | $449M | $599.0B | $134.1B | $368M |
| Cash & Equiv.Liquid assets | $3M | $20M | $343.3B | $231.8B | $106M |
| Total DebtShort + long-term debt | $50M | $469M | $942.4B | $365.9B | $473M |
| Interest CoverageEBIT ÷ Interest expense | 6.48x | -1.02x | 0.74x | 0.48x | 0.60x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $6,074 for HRZN. Over the past 12 months, BAC leads with a +28.1% total return vs HRZN's -26.7%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs HRZN's -11.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +36.7% | -12.7% | -0.5% | +1.1% | -28.1% |
| 1-Year ReturnPast 12 months | -23.8% | -10.7% | +21.8% | +28.1% | -26.7% |
| 3-Year ReturnCumulative with dividends | +42.2% | -22.4% | +138.2% | +103.0% | -31.5% |
| 5-Year ReturnCumulative with dividends | +42.2% | -23.3% | +118.2% | +47.1% | -39.3% |
| 10-Year ReturnCumulative with dividends | +42.2% | +85.3% | +465.8% | +368.2% | +43.1% |
| CAGR (3Y)Annualised 3-year return | +12.4% | -8.1% | +33.6% | +26.6% | -11.8% |
Risk & Volatility
Evenly matched — KGEI and BAC each lead in 1 of 2 comparable metrics.
Risk & Volatility
KGEI is the less volatile stock with a -0.38 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BAC currently trades 97.3% from its 52-week high vs HRZN's 51.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.38x | 0.65x | 0.94x | 0.86x | 0.85x |
| 52-Week HighHighest price in past year | $8.27 | $7.50 | $337.25 | $57.55 | $8.46 |
| 52-Week LowLowest price in past year | $3.35 | $4.48 | $262.71 | $43.66 | $3.80 |
| % of 52W HighCurrent price vs 52-week peak | +64.8% | +74.3% | +95.1% | +97.3% | +51.5% |
| RSI (14)Momentum oscillator 0–100 | 47.3 | 49.9 | 59.1 | 68.3 | 56.9 |
| Avg Volume (50D)Average daily shares traded | 221K | 298K | 7.0M | 31.7M | 918K |
Analyst Outlook
Evenly matched — JPM and HRZN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: KGEI as "Buy", TPVG as "Hold", JPM as "Buy", BAC as "Buy", HRZN as "Hold". Consensus price targets imply 60.7% upside for TPVG (target: $9) vs -2.5% for HRZN (target: $4). For income investors, HRZN offers the higher dividend yield at 28.76% vs JPM's 1.86%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $8.95 | $339.75 | $61.13 | $4.25 |
| # AnalystsCovering analysts | 1 | 12 | 61 | 54 | 22 |
| Dividend YieldAnnual dividend ÷ price | — | +18.4% | +1.9% | +2.3% | +28.8% |
| Dividend StreakConsecutive years of raises | — | 0 | 15 | 12 | 1 |
| Dividend / ShareAnnual DPS | — | $1.02 | $5.95 | $1.27 | $1.25 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.0% | 0.0% | +3.9% | +5.1% | 0.0% |
HRZN leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). KGEI leads in 1 (Profitability & Efficiency). 2 tied.
KGEI vs TPVG vs JPM vs BAC vs HRZN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is KGEI or TPVG or JPM or BAC or HRZN a better buy right now?
For growth investors, TriplePoint Venture Growth BDC Corp.
(TPVG) is the stronger pick with 36. 6% revenue growth year-over-year, versus -22. 4% for Kolibri Global Energy Inc. (KGEI). Horizon Technology Finance Corporation (HRZN) offers the better valuation at 4. 2x trailing P/E (6. 5x forward), making it the more compelling value choice. Analysts rate Kolibri Global Energy Inc. (KGEI) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — KGEI or TPVG or JPM or BAC or HRZN?
On trailing P/E, Horizon Technology Finance Corporation (HRZN) is the cheapest at 4.
2x versus JPMorgan Chase & Co. at 16. 0x. On forward P/E, TriplePoint Venture Growth BDC Corp. is actually cheaper at 6. 0x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Horizon Technology Finance Corporation wins at 0. 27x versus TriplePoint Venture Growth BDC Corp. 's 5. 88x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — KGEI or TPVG or JPM or BAC or HRZN?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +118. 2%, compared to -39. 3% for Horizon Technology Finance Corporation (HRZN). Over 10 years, the gap is even starker: JPM returned +465. 8% versus KGEI's +42. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — KGEI or TPVG or JPM or BAC or HRZN?
By beta (market sensitivity over 5 years), Kolibri Global Energy Inc.
(KGEI) is the lower-risk stock at -0. 38β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately -346% more volatile than KGEI relative to the S&P 500. On balance sheet safety, Kolibri Global Energy Inc. (KGEI) carries a lower debt/equity ratio of 25% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — KGEI or TPVG or JPM or BAC or HRZN?
By revenue growth (latest reported year), TriplePoint Venture Growth BDC Corp.
(TPVG) is pulling ahead at 36. 6% versus -22. 4% for Kolibri Global Energy Inc. (KGEI). On earnings-per-share growth, the picture is similar: Horizon Technology Finance Corporation grew EPS 756. 3% year-over-year, compared to -15. 7% for Kolibri Global Energy Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — KGEI or TPVG or JPM or BAC or HRZN?
TriplePoint Venture Growth BDC Corp.
(TPVG) is the more profitable company, earning 50. 6% net margin versus -6. 6% for Horizon Technology Finance Corporation — meaning it keeps 50. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TPVG leads at 77. 9% versus -4. 0% for HRZN. At the gross margin level — before operating expenses — TPVG leads at 83. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is KGEI or TPVG or JPM or BAC or HRZN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Horizon Technology Finance Corporation (HRZN) is the more undervalued stock at a PEG of 0. 27x versus TriplePoint Venture Growth BDC Corp. 's 5. 88x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, TriplePoint Venture Growth BDC Corp. (TPVG) trades at 6. 0x forward P/E versus 14. 4x for JPMorgan Chase & Co. — 8. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TPVG: 60. 7% to $8. 95.
08Which pays a better dividend — KGEI or TPVG or JPM or BAC or HRZN?
In this comparison, HRZN (28.
8% yield), TPVG (18. 4% yield), BAC (2. 3% yield), JPM (1. 9% yield) pay a dividend. KGEI does not pay a meaningful dividend and should not be held primarily for income.
09Is KGEI or TPVG or JPM or BAC or HRZN better for a retirement portfolio?
For long-horizon retirement investors, Kolibri Global Energy Inc.
(KGEI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 38)). Both have compounded well over 10 years (KGEI: +42. 2%, HRZN: +43. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between KGEI and TPVG and JPM and BAC and HRZN?
These companies operate in different sectors (KGEI (Energy) and TPVG (Financial Services) and JPM (Financial Services) and BAC (Financial Services) and HRZN (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: KGEI is a small-cap deep-value stock; TPVG is a small-cap high-growth stock; JPM is a large-cap deep-value stock; BAC is a large-cap deep-value stock; HRZN is a small-cap high-growth stock. TPVG, JPM, BAC, HRZN pay a dividend while KGEI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.